TMIC-42. LOCAL TISSUE METABOLOMICS BASED BIOMARKERS OF RESPONSE TO THERAPY FOR GLIOBLASTOMA

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system (CNS), with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant trans...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Rajani, Karishma, Carlstrom, Lucas, Jacobs, Joshua, Schroeder, Mark, Olson, Ian, Wang, Xuewei, Sarkaria, Jann, Burns, Terry
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Tumor Microenvironment
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846014/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1076
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller